FASEB Journal

Oncology & Cancer

New strategy to reduce cancer drug's cardiotoxic effects

Doxorubicin (Doxo) is a widely used chemotherapeutic drug for cancer, though it can have toxic effects on the heart. A recent animal study published in The FASEB Journal investigated whether the cardioregulatory protein chromogranin ...

Medical research

New medication gives aging mice bigger muscles

It is common knowledge that as people grow older they lose muscle mass and bone. Researchers from Aarhus University, Denmark, working together with researchers at Erasmus Medical Center in Rotterdam, have now studied a new ...

Cardiology

Study suggests novel biomarker for predicting AFib progression

A human study published in The FASEB Journal suggests a novel type of biomarker to predict the progression of atrial fibrillation (AF), the most common form of irregular heart rhythm. Despite inconsistent evidence to date, ...

Immunology

Stopping inflammation from becoming chronic

An international research team led by Friedrich Schiller University in Jena has developed a highly sensitive cell model to study the complex effects – and side effects – of anti-inflammatory drugs, with the ultimate aim ...

page 13 from 40